Reversal of iron-induced nephrotoxicity in rats by molsidomine, a nitric oxide donor

Food and Chemical Toxicology

Volumn 46, Issue 2, 2008, Pages 537-543

  Gupta, Amit ^a   Sharma, Sameer ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acute renal failure; Aminoguanidine; Molsidomine; Nitric oxide; Nitric oxide synthase; Oxidative stress

Indexed keywords

AMINOGUANIDINE; CREATININE; GLUTATHIONE; IRON; LIPID; MOLSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRILOTRIACETIC ACID; TUMOR NECROSIS FACTOR ALPHA; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; STATISTICAL SIGNIFICANCE; UPREGULATION; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CARCINOGENS; CREATININE; ENZYME INHIBITORS; FERRIC COMPOUNDS; GUANIDINES; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; LIPID PEROXIDATION; MALE; MOLSIDOMINE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRILOTRIACETIC ACID; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 37349031069     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.08.041     Document Type: Article

References (44)

1. Aggarwal A., and Nick H.S. Renal response to tissue injury: lessons from heme oxygenase-1 ablation and expression. J. Am. Soc. Nephrol. 11 (2000) 965-973
2. Aruoma O.I., Halliwell B., et al. Damage to the bases in DNA induction by hydrogen peroxide and ferric ion chelates. J. Biol. Chem. 264 (1989) 20509-20512
3. Awai M., Narasaki M., Yamanoi Y., and Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am. J. Pathol. 95 (1979) 663-673
4. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide and peroxynitrite: the good, bad and the ugly. Am. J. Physiol. 271 (1996) C1424-C1437
5. Chander V., and Chopra K. Molsidomine, a nitric oxide donor and l-arginine protects against rhabdomylosis-induced myoglobinuric acute renal failure. Biochem. Biophys. Acta 1723 (2005) 208-214
6. Chander V., and Chopra K. Nifedipine attenuates changes in nitric oxide levels, renal oxidative stress, and nephrotoxicity induced by cyclosporine. Ren. Fail. 27 4 (2005) 441-450
7. Chander V., and Chopra K. Renal protective effect of molsidomine and l-arginine in ischemia-reperfusion induced injury in rats. J. Surg. Res. 128 1 (2005) 132-139
8. Chen L., Wang Y., et al. Molecular mechanisms by which iron induces nitric oxide synthesis in cultured proximal tubule cells. Exp. Nephrol. 9 (2001) 198-204
9. Chen L., Zhang B.H., et al. Evidence suggesting that nitric oxide mediates iron-induced toxicity in cultured proximal tubule cells. Am. J. Physiol. Ren. 274 (1998) F18-F25
10. Chintala M.S., Chiu P.J., Vemulapalli S., Watkins R.W., and Sybertz E.J. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naun. Schmied. Arch. Pharmacol. 348 (1993) 305-310
11. Clancy R.M., Leszczynska-Piziak J., and Abramson S.B. Nitric oxide, an endothelial cell relaxing factor, inhibits neutrophil superoxide anion production via direct action on NADPH-oxidase. J. Clin. Invest. 90 (1992) 1116-1121
12. Clark S.C., Sudershan C., et al. Modulation of reperfusion injury after single lung transplantation by pentoxifylline, inositol polyanions and SIN-1. J. Thorac. Cardivasc. Surg. 117 (1999) 556-564
13. Di Rosa M., Radomski M., Carnuccio R., and Moncada S. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172 (1990) 1246-1252
14. Eguchi K., Akiyama T., et al. Apoptosis and 8-hydroxydeoxyguanosine levels in renal tissue after an injection of ferric nitrilotriacetate, a renal carcinogen, in male Wistar rats maintained on Vitamin E-deficient, normal or supplemented diets. Pathyphysiology 6 (1999) 149-156
15. Gruetter C.A., Barry B.K., McNamara D.B., Gruetter D.Y., Kadowitz P.J., and Ignarro L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J. Cycl. Nucleot. Res. 5 (1979) 211-224
16. Hamazaki S., Okada S., et al. Nephrotoxicity of ferric nitrilotriacetate: an electron-microscopic and metabolic study. Am. J. Physiol. 123 (1986) 343-350
17. Hamazaki S., Okada S., Ebina Y., and Midorikawa O. Acute renal failure and glycosuria induced by ferric nitrilotriacetate in rats. Toxicol. Appl. Pharmacol. 77 (1985) 267-274
18. Hiroyasu M., Ozeki M., Kohda H., Echizenya M., Tanaka T., Hiai H., and Toyokuni S. Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am. J. Pathol. 160 (2002) 419-424
19. Iqbal M., Okazaki Y., et al. Nitroglycerin, a nitric oxide generator attenuates ferric nitrilotriacetate-induced renal oxidative stress, hyperproliferative response and necrosis in ddY mice. Biochem. Biophys. Acta 1623 2-3 (2003) 98-108
20. Jacobs A. In: Jacobs A., and Worwood M. (Eds). Iron in Biochemistry and Medicine II (1980), Academic Press, York/London 427-459
21. Jollow D.J., Mitchell L.R., Zampaglione N., and Gillete J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 11 (1974) 151-169
22. Kadkhodaee M., and Gol A. The role of nitric oxide in iron-induced rat renal injury. Hum. Exp. Toxicol. 23 (2004) 533-536
23. Kagan V.E., Kozlov A.V., et al. Antioxidant mechanisms of nitric oxide against iron-catalyzed oxidative stress in cells. Antioxid. Redox Signal. 3 2 (2001) 189-202
24. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 186 (1978) 189
25. Kukovetz W.R., and Holzmann S. Cyclic-GMP as the mediator of molsidomine-induced vasodilatation. Eur. J. Pharmacol. 122 (1986) 103-109
26. Liochev S.I., and Fridovich I. The Haber-Weiss cycle-70 years later: an alternative view. Redox Rep. 7 (2002) 55-57
27. Liu M., Okada S., et al. Radical promoting free iron level in serum of rats treated with other iron chelate complexes. Acta Med. Okayama 45 (1993) 401-408
28. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
29. Okada S. Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol. Int. 46 (1996) 311-332
30. Okada S., and Midorikawa O. Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn. Arch. Inten. Med. 29 (1982) 485-491
31. Preece N.E., Evabs P.F., Howarth J.A., King L.J., and Parke D.V. The induction of autoxidative tisue by iron nitrilotriacetate in rats and mice. Toxicol. Appl. Pharmacol. 93 (1988) 89-100
32. Rodriguez-Pena A., Garcia-Criado F.J., et al. Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats. Am. J. Transplant. 4 10 (2004) 1605-1613
33. Sahna E., Parlakpinar H., et al. Effects of aminoguanidine against renal ischaemia-reperfusion injury in rats. Cell Biochem. Funct. 24 2 (2006) 137-141
34. Shimoi K., Shen B., et al. Protection by αG-Rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate. Jpn. J. Cancer Res. 88 (1997) 453-460
35. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 20 (1996) 553-566
36. Toyokuni S. Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep. 7 4 (2002) 189-197
37. Toyokuni S., Uchida K., et al. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Sci. USA 91 (1994) 2620-2646
38. Umemura T.Y., Sai K., et al. Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in rat kidney after ferric nitrilotriacetate administration. Cancer Lett. 54 (1990) 95-100
39. Unanue E., and Dixon F.J. Experimental glomerulonephritis: immunological events and pathologic mechanism. Adv. Immunol. 6 (1967) 1-90
40. Varley H. The plasma proteins. In: Varley H. (Ed). Practical Clinical Biochemistry (1988), CBS, Delhi 183-186
41. Waz W.R., Van Liew J.B., and Feld L.G. Nitric oxide metabolism following unilateral renal ischemai-reperfusion injury in rats. Pediatr. Nephrol. 12 (1998) 26-29
42. Weinberg E.D. Iron depletion: defense against intracellular infections and neoplasia. Life Sci. 50 (1992) 1289
43. Wu Z., and Qiu L. Effect of nitric oxide on iron-mediated cytotoxicity in primary cultured renal proximal tubules. Cell Biochem. Funct. 19 4 (2001) 237-247
44. Zhang D., Okada S., et al. An improved simple colorimetric method for the quantization of non-bound iron in serum. Biochem. Mol. Biol. Int. 35 (1995) 635-641